✦ LIBER ✦

Sirolimus + mTOR inhibitors promising for recurrent gliomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A dose escalation trial for the combinat

✍ Phioanh Leia Nghiemphu, Albert Lai, Richard M. Green, David A. Reardon, Timothy 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 194 KB

mTOR inhibitors and sorafenib for recurr

✍ Oliver Waidmann; Wolf-Peter Hofmann; Stefan Zeuzem; Joerg Trojan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 215 KB

Phase 2 trial of talampanel, a glutamate

✍ Fabio M. Iwamoto; Teri N. Kreisl; Lyndon Kim; J. Paul Duic; John A. Butman; Paul 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

A prospective randomised, open-labeled,

✍ Andreas A Schnitzbauer; Carl Zuelke; Christian Graeb; Justine Rochon; Itxarone B 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 454 KB

Epithelial Growth Factor Receptor inhibi

✍ M. Preusser; E. Gelpi; A. Rottenfusser; K. Dieckmann; G. Widhalm; W. Dietrich; A 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 379 KB

A phase I clinical trial of the mTOR inh

✍ M. Abu-Khalaf; A. Santin; E. Ratner; D. Silasi; K. ElSahwi; L. Baker; M. Luther; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 111 KB